Turquoise Health’s effort to make procedure prices more usable before care could bring more patient cost questions into pre-op visits, referral decisions, and scheduling workflows.
The San Diego health technology company describes its platform as a way for health care organizations to work with pricing, contracting, and compliance data. Turquoise Health provides healthcare pricing data and analysis primarily through enterprise tools for health care organizations, while also offering or powering consumer-facing price-comparison tools that allow individual patients to compare prices and estimates before care.
The company’s broader relevance for physicians is not simply consumer shopping; it is the growing possibility that cost-comparison and cost-efficiency information and analysis will become part of the administrative pathway before planned care is delivered.
Federal policy created much of the data environment behind companies such as Turquoise. CMS says hospitals have been required since Jan. 1, 2021, to make standard charge information available online through machine-readable files and consumer-friendly information for shoppable services. Separate federal Transparency in Coverage rules also require health plans and issuers to make certain pricing information available.
The challenge is that raw transparency data are not the same as usable guidance for patients. KFF has reported that hospital price-transparency data can be messy, inconsistent, and confusing, making comparison difficult for patients and researchers. KFF Health News has also reported that it remains unclear whether transparency rules will increase competition and lower costs. The American Hospital Association supports price transparency but argues that aligning federal requirements would avoid confusion, duplication, and unnecessary administrative burden.
Turquoise says more than 300 organizations use its platform. In March, Business Wire reported that more than 280 customers use the company’s platform, including 10 of the top 25 health systems, four of the five national payers, nine of the top 10 pharmaceutical companies, and six of the top 10 insurance brokers.
For San Diego physicians, the pressure point is not medical decision-making alone. It is the coordination among physician recommendations, payer authorizations, facility selection, patient estimates, scheduling, and pre-op clearance. The issue is likely to surface most often in elective or planned care, including imaging, endoscopy, orthopedics, obstetric procedures, interventional cardiology, and outpatient surgery.
Even when pricing data are available, patients may still need payer-specific benefit information, deductible status, and prior-authorization details to understand the likely out-of-pocket cost.
For physician practices, the practical issue is not whether doctors should become billing experts. The core challenge lies in connecting clinical advice to a dependable administrative process. This pathway must enable patients to understand financial obligations, various site-of-care options, and insurance limitations before scheduling any procedures.